WEIGHT MANAGEMENT RESEARCH
Retatrutide 20 mg
$189.99LABORATORY REFERENCE MATERIAL. VERIFY LOT-SPECIFIC DOCUMENTATION.
Retatrutide is an investigational single-peptide agonist studied for combined activity at GIP, GLP-1 and glucagon receptors. It remains a clinical-development compound and is not an approved finished drug.
- Triple-receptor pharmacology research
- Metabolic signaling studies
- Investigational compound; human use is not authorized
20 MG LYOPHILIZED RESEARCH MATERIAL | RESEARCH USE ONLY
1